Product Information
VERAPAMIL ER PM 300 MG CAPSULE is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $8.0273 per EA under NDC 52536048737. Its NADAC has been published 38 times since Oct 8, 2025.
Strength
300 mg/1
Manufacturer
Wilshire Pharmaceuticals Inc.NDC
52536048737
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020943On Market Since
11/26/2024
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL ER PM 300 MG CAPSULE has been published 38 times since Oct 8, 2025, and over the history we have for it it has risen 5.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.0273 per EA |
|---|---|
| All-time high | $8.0429 (May 13, 2026) |
| All-time low | $7.5962 (Oct 8, 2025) |
| 52-week high | $8.0429 |
| 52-week low | $7.5962 |
| Median price | $7.7947 |
| Average price | $7.8007 |
| Largest weekly change | +2.3% (Feb 18, 2026) |
| Weeks tracked | 38 |
| Tracking since | Oct 8, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VERAPAMIL ER PM 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL ER PM 300 MG CAPSULE, manufactured by Wilshire Pharmaceuticals Inc., is $8.0273 per EA (NDC 52536048737), effective Jun 24, 2026.
How has the price of VERAPAMIL ER PM 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VERAPAMIL ER PM 300 MG CAPSULE has risen 5.7%. It has been tracked across 38 weekly CMS publications since Oct 8, 2025.
What are the highest and lowest recorded NADAC prices for VERAPAMIL ER PM 300 MG CAPSULE?
Since Oct 8, 2025, the NADAC for VERAPAMIL ER PM 300 MG CAPSULE has ranged from a low of $7.5962 (Oct 8, 2025) to a high of $8.0429 (May 13, 2026), with a median of $7.7947 per EA.
Are there cheaper alternatives to VERAPAMIL ER PM 300 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as VERAPAMIL ER PM 300 MG CAPSULE, but none are currently priced below it.
Who manufactures VERAPAMIL ER PM 300 MG CAPSULE?
VERAPAMIL ER PM 300 MG CAPSULE (NDC 52536048737) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification